MY148491A
(en )
2013-04-30
FUSED BICYCLIC mTOR INHIBITORS
TW200738725A
(en )
2007-10-16
Unsaturated mTOR inhibitors
TW200740776A
(en )
2007-11-01
N-phenylbenzotriazolyl c-kit inhibitors
IL260127B
(en )
2022-04-01
mek inhibitors and methods of using them
UA84712C2
(en )
2008-11-25
N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
TW200519111A
(en )
2005-06-16
N3-substituted imidazopyridine C-KIT inhibitors
GEP20105024B
(en )
2010-06-25
Fused heterocyclic compound
NO2017019I2
(no )
2017-05-04
Enzalutamid eller et farmasøytisk akseptabelt salt derav
MY146111A
(en )
2012-06-29
Acylaminopyrazoles as fgfr inhibitors
EA200801428A1
(ru )
2008-10-30
Производные пиридиазинона для лечения опухолей
NZ593440A
(en )
2013-02-22
Aminopyrazole compounds useful for inhibiting chk1
AP2378A
(en )
2012-03-08
Sulfonamide derivatives for the treatment of diseases.
AP2359A
(en )
2012-01-30
Sulfonamide derivatives for the treatment of diseases.
MXPA06009475A
(es )
2007-05-15
Derivados de quinazolina y usos terapeuticos de los mismos.
ATE432281T1
(de )
2009-06-15
Pyrrolotriazin-kinasehemmer
UA96304C2
(en )
2011-10-25
2-METHYLMORPHOLINE PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
UA96969C2
(en )
2011-12-26
Acylaminopyrazoles as fgfr inhibitors
ZA200801332B
(en )
2009-10-28
Pentacyclic kinase inhibitors
TW200639156A
(en )
2006-11-16
New compounds
WO2007120333A3
(en )
2008-01-10
Tetracyclic kinase inhibitors
IL178261A0
(en )
2006-12-31
Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
UA96745C2
(en )
2011-12-12
PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
UA94070C2
(ru )
2011-04-11
КОНДЕНСИРОВАННЫЕ БИЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ mTOR
TW200626588A
(en )
2006-08-01
(Arylamidoaryl)cyanoguanidine compounds
GB0515025D0
(en )
2005-08-31
Organic compounds